No significant impact of patient age and prior treatment profile with docetaxel on the efficacy of cabazitaxel in patient with castration-resistant prostate cancer

BACKGROUND: The correlation of the oncological outcomes of docetaxel and cabazitaxel in Japanese metastatic castration-resistant prostate cancer (mCRPC) patients has not been unclear. MATERIALS AND METHODS: This study included a total of 47 consecutive Japanese mCRPC patients treated with cabazitaxe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Chemother Pharmacol
Autores principales: Kosaka, Takeo, Hongo, Hiroshi, Watanabe, Keitaro, Mizuno, Ryuichi, Kikuchi, Eiji, Oya, Mototsugu
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6267665/
https://ncbi.nlm.nih.gov/pubmed/30283980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-018-3698-1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares